Enviar artigo por via de e-mail Transport Platform Synthesis for Drug Development
- Autores: Stukalov Y.V.1, Grigor’eva E.Y.1, Kulakov V.N.2, Baryshnikov A.Y.1
-
Afiliações:
- N. N. Blokhin Russian Cancer Research Center
- A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
- Edição: Volume 51, Nº 6 (2017)
- Páginas: 480-481
- Seção: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/244661
- DOI: https://doi.org/10.1007/s11094-017-1637-9
- ID: 244661
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
Asynthetic scheme for a transport platform for the creation of new diagnostic and therapeutic antitumor drugs that was based on a dendrimer with a core of pentaerythritol tetraglycidyl ether (TGEPE) and dendra with diallylamine was developed. The transport platform was promising for designing targeted antitumor agents for magnetic resonance tomography and nuclear medicine.
Palavras-chave
Sobre autores
Yu. Stukalov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Rússia, 24 Kashirskoe Shosse, Moscow, 115478
E. Grigor’eva
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Rússia, 24 Kashirskoe Shosse, Moscow, 115478
V. Kulakov
A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
Email: chem@folium.ru
Rússia, 46 Zhivopisnaya St, Moscow, 123182
A. Baryshnikov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Rússia, 24 Kashirskoe Shosse, Moscow, 115478
Arquivos suplementares
